1.
Massimo Breccia, Adriano Salaroli, Giuseppina Loglisci, Paola Finsinger, Alessandra Serrao, Giuliana Alimena. MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine. Haematologica 2012;97(2):e2-e2; https://doi.org/10.3324/haematol.2011.059808.